All this good news is keeping the stock at such a low price. Guess the promise of tomorrow is what keeps this board busy. How many tomorrow’s until there are none of us left. How old is Linda powers ?
If this stock was worth more, it would worth more. Geeeeez
Combo trial for recurrent GBM requires a significant resection to qualify for the trial which significantly improve the odds of survival versus the DCVax-L P3 recurrent GBM arm did not have a resection. Not going to be comparable data.